Linghua Meng
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 18, 2025
PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitors.Xu Zhang, Jiao Xu, Xuan Wang
|Apr 11, 2023
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.Xu Zhang, Yuxiang Wang, Xi Zhang
|May 23, 2022
Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma.Hui Xing, Mengshi Gao, Yuxiang Wang
|Mar 31, 2021
PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma.Qin Xie, Shuaishuai Chi, Yanfen Fang
|Jan 15, 2021
Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells.Yu-Xiang Wang, Xu Zhang, Qing-Yang Ma
|Jan 24, 2019
Membrane metallo-endopeptidase mediates cellular senescence induced by oncogenic PIK3CAH1047R accompanied with pro-tumorigenic secretome.Xue-Ling Liu, Jia-Li Liu, Yi-Chao Xu
Pageof 1
